Literature DB >> 6206922

Two distinct strio-nigral substance P pathways in the rat: an experimental immunohistochemical study.

J Kohno, S Shiosaka, K Shinoda, S Inagaki, M Tohyama.   

Abstract

Re-examination of the strio-nigral substance P (SP) tract by means of an experimental immunohistochemical method in the rats demonstrated the presence of two distinct pathways from the nucleus caudatus putamen (CP) to the substantia nigra (SN). Destruction of the posterior portion of the CP resulted in the disappearance of SP-positive fibers in the SN pars lateralis but not in the SN pars compacta or reticulata. On the other hand, destruction of the ventrolateral portion of the anterior portion of the CP caused the disappearance of SP-positive fibers in the SN pars compacta and pars reticulata but not in the SN pars lateralis. In addition, destruction of the dorsal portion of the anterior portion of the CP, where 3-6 cell islets of SP-positive cells are located, failed to decrease SP-positive fibers in any of the subdivisions of the SN. These findings strongly suggest that SP-positive neurons in the posterior portion of the CP project to the SN pars lateralis (posterior strio-nigral SP tract), SP-positive cells in the lateroventral part of the anterior portion of the CP extend to the SN pars compacta and pars reticulata, but SP-positive cells in the dorsal part of the anterior portion of the CP do not innervate the SN.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6206922     DOI: 10.1016/0006-8993(84)91070-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.

Authors:  W S Young; T I Bonner; M R Brann
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

2.  Tachykinin-immunoreactive neurons in developing feline neostriatum: somatodendritic morphogenesis demonstrated by combined immunohistochemistry/Golgi impregnation-gold toning.

Authors:  Robin Fisher; Marea Boylan
Journal:  Dev Neurosci       Date:  2011-02-23       Impact factor: 2.984

3.  Afferent connections of the nucleus centralis amygdalae. A horseradish peroxidase study and literature survey.

Authors:  H P Volz; G Rehbein; J Triepel; M M Knuepfer; H Stumpf; G Stock
Journal:  Anat Embryol (Berl)       Date:  1990

4.  Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.

Authors:  I Christensson-Nylander; M Herrera-Marschitz; W Staines; T Hökfelt; L Terenius; U Ungerstedt; C Cuello; W H Oertel; M Goldstein
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

5.  Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis.

Authors:  M Herrera-Marschitz; I Christensson-Nylander; T Sharp; W Staines; M Reid; T Hökfelt; L Terenius; U Ungerstedt
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

6.  Acute reduction of brain substance P induced by nicotine.

Authors:  N E Naftchi; H Maker; E Lapin; J Sleis; A Lajtha; S Leeman
Journal:  Neurochem Res       Date:  1988-04       Impact factor: 3.996

7.  The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey.

Authors:  C R Gerfen; K G Baimbridge; J J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

8.  The postsynaptic targets of substance P-immunoreactive terminals in the rat neostriatum with particular reference to identified spiny striatonigral neurons.

Authors:  J P Bolam; P N Izzo
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

9.  Conservation of the Direct and Indirect Pathway Dichotomy in Mouse Caudal Striatum With Uneven Distribution of Dopamine Receptor D1- and D2-Expressing Neurons.

Authors:  Kumiko Ogata; Fuko Kadono; Yasuharu Hirai; Ken-Ichi Inoue; Masahiko Takada; Fuyuki Karube; Fumino Fujiyama
Journal:  Front Neuroanat       Date:  2022-02-04       Impact factor: 3.856

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.